Great validation from a US KOL and well respected leading nerve repair / trauma surgeon on what the company has been saying about Remplir for some time.
Dr Valerio says Remplir is a “breakthrough technology” and believes it will ultimately be the market leader and secure rapidly uptake and expansion globally.
- Forums
- ASX - By Stock
- OCC
- Media thread
OCC
orthocell limited
Add to My Watchlist
0.41%
!
$1.22

Media thread, page-1090
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.22 |
Change
-0.005(0.41%) |
Mkt cap ! $296.8M |
Open | High | Low | Value | Volume |
$1.22 | $1.24 | $1.21 | $336.2K | 275.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 29601 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.22 | 5274 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 28473 | 1.210 |
6 | 26272 | 1.205 |
19 | 129446 | 1.200 |
6 | 31422 | 1.195 |
8 | 55206 | 1.190 |
Price($) | Vol. | No. |
---|---|---|
1.215 | 4651 | 7 |
1.220 | 9620 | 3 |
1.225 | 4032 | 5 |
1.230 | 87 | 1 |
1.235 | 5000 | 1 |
Last trade - 15.25pm 18/06/2025 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online